Company Profile

Company Name Bloom Technology Corporation
Our Business Drug discovery and development for toxic AGEs
Address 3-14-3 Minamikumamoto, Chuo-ku, Kumamoto 860-0812, Japan Access
Phone +81-96-375-5511
Fax +81-96-206-1787
Established November 19, 2014
Capital 110 million yen (as of May 31, 2019)
Employees 9 staffs including 3 Ph.D.s (as of August, 2019)
Board of Directors CEO
Hideki Saito
Hideki Saito, CEO
Has experience of over 20 years in the development of Erythropoietin products at Chugai Parmaceutical Co., Ltd., a Roche group

Director
Kazumi Sasamoto, Ph.D.
Kazumi Sasamoto, Ph.D.
A former managing director at Dojindo Laboratories, a reagent company

Director
Tamami Sakamoto
Tamami Sakamoto
A former director of Trans Genic Ltd.

Director
Tetsuro Yamamoto, M.D., Ph.D.
Tetsuro Yamamoto, M.D., Ph.D.
A former professor of pathology at Kumamoto University

Director
Ken Minami
Ken Minami
A vice president of Hibiki Partners, a venture capital firm

Director
Jun-ichi Imoto
Jun-ichi Imoto
A senior venture capitalist at Nissay Capital LTD.

Auditor
Masahito Douzono
Masahito Douzono
Certified Public Accountant, Douzono CPA office

PAGE TOP